Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Radhe Mohan

Showing results (331-340 of 345) with videos related to

Pageof 35
Sort By:
Radiation Oncology (London, England)|May 5, 2016
Establishing the feasibility of the dosimetric compliance criteria of RTOG 1308: phase III randomized trial comparing overall survival after photon versus proton radiochemotherapy for inoperable stage II-IIIB NSCLCTawfik Giaddui, Wenzhou Chen, Jialu Yu, et al.
JAMA Oncology|July 21, 2017
Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Final Results of a Phase 2 StudyJoe Y Chang, Vivek Verma, Ming Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2018
Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung CancerZhongxing Liao, J Jack Lee, Ritsuko Komaki, et al.
Physics in Medicine and Biology|April 8, 2022
Roadmap: helium ion therapyAndrea Mairani, Stewart Mein, Eleanor Blakely, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2016
Clinical Outcomes and Patterns of Disease Recurrence After Intensity Modulated Proton Therapy for Oropharyngeal Squamous CarcinomaG Brandon Gunn, Pierre Blanchard, Adam S Garden, et al.
International Journal of Radiation Oncology, Biology, Physics|June 30, 2016
Intensity Modulated Proton Therapy Versus Intensity Modulated Photon Radiation Therapy for Oropharyngeal Cancer: First Comparative Results of Patient-Reported OutcomesTerence T Sio, Huei-Kai Lin, Qiuling Shi, et al.
Advances in Radiation Oncology|March 18, 2021
The Reality of Randomized Controlled Trials for Assessing the Benefit of Proton Therapy: Critically Examining the Intent-to-Treat Principle in the Presence of Insurance DenialMike Hernandez, J Jack Lee, Beow Y Yeap, et al.
Neuro-Oncology|August 5, 2020
Proton therapy reduces the likelihood of high-grade radiation-induced lymphopenia in glioblastoma patients: phase II randomized study of protons vs photonsRadhe Mohan, Amy Y Liu, Paul D Brown, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 26, 2016
Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer - A case matched analysisPierre Blanchard, Adam S Garden, G Brandon Gunn, et al.
International Journal of Radiation Oncology, Biology, Physics|December 9, 2025
Bayesian Learning to Reduce Cardiac Risk for Locally Advanced NSCLC Patients Based on Personalized Radiotherapy PrescriptionRuitao Lin, Mei Chen, Xiaodong Zhang, et al.
Pageof 35

Showing results (331-340 of 345) with videos related to

Sort By:
Pageof 35
Radiation Oncology (London, England)|May 5, 2016
Establishing the feasibility of the dosimetric compliance criteria of RTOG 1308: phase III randomized trial comparing overall survival after photon versus proton radiochemotherapy for inoperable stage II-IIIB NSCLCTawfik Giaddui, Wenzhou Chen, Jialu Yu, et al.
JAMA Oncology|July 21, 2017
Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Final Results of a Phase 2 StudyJoe Y Chang, Vivek Verma, Ming Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2018
Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung CancerZhongxing Liao, J Jack Lee, Ritsuko Komaki, et al.
Physics in Medicine and Biology|April 8, 2022
Roadmap: helium ion therapyAndrea Mairani, Stewart Mein, Eleanor Blakely, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2016
Clinical Outcomes and Patterns of Disease Recurrence After Intensity Modulated Proton Therapy for Oropharyngeal Squamous CarcinomaG Brandon Gunn, Pierre Blanchard, Adam S Garden, et al.
International Journal of Radiation Oncology, Biology, Physics|June 30, 2016
Intensity Modulated Proton Therapy Versus Intensity Modulated Photon Radiation Therapy for Oropharyngeal Cancer: First Comparative Results of Patient-Reported OutcomesTerence T Sio, Huei-Kai Lin, Qiuling Shi, et al.
Advances in Radiation Oncology|March 18, 2021
The Reality of Randomized Controlled Trials for Assessing the Benefit of Proton Therapy: Critically Examining the Intent-to-Treat Principle in the Presence of Insurance DenialMike Hernandez, J Jack Lee, Beow Y Yeap, et al.
Neuro-Oncology|August 5, 2020
Proton therapy reduces the likelihood of high-grade radiation-induced lymphopenia in glioblastoma patients: phase II randomized study of protons vs photonsRadhe Mohan, Amy Y Liu, Paul D Brown, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 26, 2016
Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer - A case matched analysisPierre Blanchard, Adam S Garden, G Brandon Gunn, et al.
International Journal of Radiation Oncology, Biology, Physics|December 9, 2025
Bayesian Learning to Reduce Cardiac Risk for Locally Advanced NSCLC Patients Based on Personalized Radiotherapy PrescriptionRuitao Lin, Mei Chen, Xiaodong Zhang, et al.
Pageof 35